These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 35398739)
1. Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease. Kumar N; Kumar V; Anand P; Kumar V; Ranjan Dwivedi A; Kumar V Bioorg Med Chem; 2022 May; 61():116742. PubMed ID: 35398739 [TBL] [Abstract][Full Text] [Related]
2. Multi-Target-Directed Ligands as an Effective Strategy for the Treatment of Alzheimer's Disease. Kumar B; Thakur A; Dwivedi AR; Kumar R; Kumar V Curr Med Chem; 2022; 29(10):1757-1803. PubMed ID: 33982650 [TBL] [Abstract][Full Text] [Related]
3. Recent Developments in Tacrine-based Hybrids as a Therapeutic Option for Alzheimer's Disease. Yamali C; Donmez S Mini Rev Med Chem; 2023; 23(7):869-880. PubMed ID: 36464869 [TBL] [Abstract][Full Text] [Related]
4. A comprehensive review of multi-target directed ligands in the treatment of Alzheimer's disease. Pathak C; Kabra UD Bioorg Chem; 2024 Mar; 144():107152. PubMed ID: 38290187 [TBL] [Abstract][Full Text] [Related]
5. Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease. Uliassi E; Bergamini C; Rizzardi N; Naldi M; Cores Á; Bartolini M; Carlos Menéndez J; Bolognesi ML Bioorg Med Chem; 2023 Aug; 91():117419. PubMed ID: 37487339 [TBL] [Abstract][Full Text] [Related]
6. Virtual screening and molecular dynamics simulation approach for the identification of potential multi-target directed ligands for the treatment of Alzheimer's disease. Jangid K; Devi B; Sahoo A; Kumar V; Dwivedi AR; Thareja S; Kumar R; Kumar V J Biomol Struct Dyn; 2024; 42(1):509-527. PubMed ID: 37114423 [TBL] [Abstract][Full Text] [Related]
7. A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer's disease. Jalili-Baleh L; Babaei E; Abdpour S; Nasir Abbas Bukhari S; Foroumadi A; Ramazani A; Sharifzadeh M; Abdollahi M; Khoobi M Eur J Med Chem; 2018 May; 152():570-589. PubMed ID: 29763806 [TBL] [Abstract][Full Text] [Related]
8. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease. Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of BACE1, MAO-B, cholinesterase enzymes, and anti-amyloidogenic potential of selected natural phytoconstituents: Multi-target-directed ligand approach. Chowdhury S; Kumar S J Food Biochem; 2021 Jan; 45(1):e13571. PubMed ID: 33249607 [TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of novel tacrine-dipicolylamine dimers that are multiple-target-directed ligands with potential to treat Alzheimer's disease. Zhang P; Wang Z; Mou C; Zou J; Xie Y; Liu Z; Benjamin Naman C; Mao Y; Wei J; Huang X; Dong J; Yang M; Wang N; Jin H; Liu F; Lin D; Liu H; Zhou F; He S; Zhang B; Cui W Bioorg Chem; 2021 Nov; 116():105387. PubMed ID: 34628225 [TBL] [Abstract][Full Text] [Related]
11. Rational drug design strategies for the development of promising multi-target directed indole hybrids as Anti-Alzheimer agents. George N; Jawaid Akhtar M; Al Balushi KA; Alam Khan S Bioorg Chem; 2022 Oct; 127():105941. PubMed ID: 35714473 [TBL] [Abstract][Full Text] [Related]
12. Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease. Li Q; He S; Chen Y; Feng F; Qu W; Sun H Eur J Med Chem; 2018 Oct; 158():463-477. PubMed ID: 30243151 [TBL] [Abstract][Full Text] [Related]
13. A molecular approach in drug development for Alzheimer's disease. Agatonovic-Kustrin S; Kettle C; Morton DW Biomed Pharmacother; 2018 Oct; 106():553-565. PubMed ID: 29990843 [TBL] [Abstract][Full Text] [Related]
14. Multi-target-directed ligands in Alzheimer's disease treatment. Bajda M; Guzior N; Ignasik M; Malawska B Curr Med Chem; 2011; 18(32):4949-75. PubMed ID: 22050745 [TBL] [Abstract][Full Text] [Related]
15. Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design. Kumar A; Tiwari A; Sharma A Curr Neuropharmacol; 2018; 16(6):726-739. PubMed ID: 29542413 [TBL] [Abstract][Full Text] [Related]
16. Effects of Linkers and Substitutions on Multitarget Directed Ligands for Alzheimer's Diseases: Emerging Paradigms and Strategies. Pravin N; Jozwiak K Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682763 [TBL] [Abstract][Full Text] [Related]
17. AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer's Disease. Wang Y; Wang H; Chen HZ Curr Neuropharmacol; 2016; 14(4):364-75. PubMed ID: 26786145 [TBL] [Abstract][Full Text] [Related]
18. Identifying natural compounds as multi-target-directed ligands against Alzheimer's disease: an in silico approach. Ambure P; Bhat J; Puzyn T; Roy K J Biomol Struct Dyn; 2019 Mar; 37(5):1282-1306. PubMed ID: 29578387 [TBL] [Abstract][Full Text] [Related]